Clinical trial
CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the…
NCT00125489 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00125489 |
|---|---|
| Title | CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi |
| Official title | Chloroquine and Sulfadoxine-Pyrimethamine Efficacy for the Treatment of Uncomplicated Falciparum Malaria in Blantyre, Malawi |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria, Plasmodium Falciparum Malaria |
| Intervention type | Drug |
| Interventions | chloroquine sulfate, sulfadoxine/pyrimethamine |
| Enrollment | 210 |
| Start date | May 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Aug 1, 2005 |
| Last update posted | Aug 27, 2010 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: